inclusion criteria: 1. adult patients aged 18-75 years old 2. patients with covid-19 showing symptoms and confirmed with positive rt pcr test and or covid-19 igm/igg rapid test 3. no history of favipiravir or oseltamivir allergy 4. consented to participate in the trial.

inclusion criteria: 1. adult patients aged 18-75 years old 2. patients with covid-19 showing symptoms and confirmed with positive rt pcr test and or covid-19 igm/igg rapid test 3. no history of favipiravir or oseltamivir allergy 4. consented to participate in the trial.

inclusion criteria: adult patients aged 18-75 years old patients with covid-19 showing symptoms and confirmed with positive rt pcr test and or covid-19 igm/igg rapid test no history of favipiravir or oseltamivir allergy consented to participate in the trial.

inclusion criteria: adult patients aged 18-75 years old patients with covid-19 showing symptoms and confirmed with positive rt pcr test and or covid-19 igm/igg rapid test no history of favipiravir or oseltamivir allergy consented to participate in the trial.

inclusion criteria: 1. adult patients aged 18-75 years old 2. patients with covid-19 showing symptoms and confirmed with positive rt pcr test and or covid-19 igm/igg rapid test 3. no history of favipiravir or oseltamivir allergy 4. consented to participate in the trial.

inclusion criteria: 1. adult patients aged 18-75 years old 2. patients with covid-19 showing symptoms and confirmed with positive rt pcr test and or covid-19 igm/igg rapid test 3. no history of favipiravir or oseltamivir allergy 4. consented to participate in the trial.